Moss Adams Wealth Advisors’s Trinity Biotech TRIB Stock Holding History

Moss Adams Wealth Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.98K	Hold	856	–	–	﹤0.01%	307
2026 Q1	$13.9K	Hold	856	–	–	﹤0.01%	270
2025 Q4	$20.3K	Hold	856	–	–	﹤0.01%	262
2025 Q3	$26.7K	Hold	856	–	–	﹤0.01%	252
2025 Q2	$16.7K	Hold	856	–	–	﹤0.01%	255
2025 Q1	$14.6K	Hold	856	–	–	﹤0.01%	217
2024 Q4	$22.6K	Hold	856	–	–	﹤0.01%	206
2024 Q3	$28.2K	Hold	856	–	–	﹤0.01%	200
2024 Q2	$54.7K	Hold	856	–	–	0.01%	170
2024 Q1	$52.4K	Buy	+856	New	+$60.1K	0.01%	151

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Moss Adams Wealth Advisors's TRIB Position: Q2 2026 in Review

Moss Adams Wealth Advisors held its Trinity Biotech (TRIB) position steady in Q2 2026 at 856 shares worth $9.98K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Moss Adams Wealth Advisors first reported a position in TRIB in Q1 2024 and has held it in 10 quarters since. The position peaked at $54.7K in Q2 2024. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

Moss Adams Wealth Advisors held 856 shares of Trinity Biotech worth $9.98K as of Q2 2026.
Moss Adams Wealth Advisors left its Trinity Biotech share count unchanged in Q2 2026.
Trinity Biotech made up ﹤0.01% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #307 holding.
Moss Adams Wealth Advisors first reported a position in Trinity Biotech in Q1 2024 and has held it in 10 quarters since.
Moss Adams Wealth Advisors's Trinity Biotech position peaked at $54.7K in Q2 2024.
19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.